Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study
Zhigang Wang, Bram Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Topics & Concepts
MedicineVedolizumabInfliximabTherapeutic drug monitoringDrugPharmacologyInternal medicineUlcerative colitisTumor necrosis factor alphaDiseasePharmaceutical studies and practicesBiosimilars and Bioanalytical MethodsImmunotherapy and Immune Responses